Bleeding Complication of Triple Therapy of Rivaroxaban, Prasugrel, and Aspirin: A Case Report and General Discussion
Hemorrhagic side effects are the bane of oral anticoagulation. Despite careful selection of medications and close monitoring, some adverse events are unavoidable. The available literature about the risks of triple oral anticoagulation therapy versus dual antiplatelet therapy does not address all of...
Saved in:
Main Authors: | Dane D. Gruenebaum, Ahmad Alsarah, Osama Alsara, Heather Laird-Fick |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2014-01-01
|
Series: | Case Reports in Cardiology |
Online Access: | http://dx.doi.org/10.1155/2014/293476 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isolated Left Main Coronary Artery Stenosis after Thoracic Radiation Therapy: To Operate or Not to Operate
by: Osama Alsara, et al.
Published: (2013-01-01) -
Risk of Gastrointestinal Bleeding with Rivaroxaban: A Comparative Study with Warfarin
by: Muhammed Sherid, et al.
Published: (2016-01-01) -
Stent Thrombosis Patients with Hyporesponsiveness to Clopidogrel, Prasugrel, and Ticagrelor: A Case Series Using Short Thromboelastography
by: Bartosz Olechowski, et al.
Published: (2016-01-01) -
Metastatic Invasive Lobular Breast Cancer Presenting Clinically with Esophageal Dysphagia
by: Lilit Karapetyan, et al.
Published: (2017-01-01) -
Risk of recurrence and bleeding in patients with cancer‐associated venous thromboembolism treated with rivaroxaban: A nationwide cohort study
by: Mette Søgaard, et al.
Published: (2019-03-01)